Abstract
The report analyzes and forecasts the pediatric vaccine market on a global and regional level. The study offers past data from 2016 to 2018 and a forecast from 2019 to 2025 based on revenue (USD Billion). The assessment of pediatric vaccine market gives a brief thought about the drivers and restraints of the pediatric vaccine market along with the impact they have on the demand over the years to come. Additionally, the report also includes the study of opportunities available in the pediatric vaccine market on a global level.
The report gives a transparent view of the pediatric vaccine market. We have included a detailed competitive scenario and portfolio of the leading vendors operating in the pediatric vaccine market. To understand the competitive landscape in the pediatric vaccine market, an analysis of Porter’s Five Forces model has also been included. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a crucial view of the pediatric vaccine market by segmenting it based on the vaccine type, disease type, technology, administration method, end-user, and region. All the segments of the pediatric vaccine market have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment comprises the current and forecast demand for the Middle East and Africa, North America, Asia Pacific, Latin America, and Europe.
Some key players operating in the global pediatric vaccine market are Mitsubishi Tanabe Pharma, Astellas Pharma, Johnson & Johnson, Pfizer, CSL Limited, GlaxoSmithKline, Serum Institute of India, Panacea Biotec, Daiichi Sankyo, and Merck.
This report segment the global pediatric vaccine market into:
Global Pediatric Vaccine Market: By Vaccine Type
Monovalent Vaccines
Multivalent Vaccines
Global Pediatric Vaccine Market: By Disease Type
Meningococcal Disease
Hepatitis
Influenza
Polio
Pneumococcal Disease
DTP
MMR (Measles, Mumps, and Rubella)
Dengue
Rotavirus
Human Papilloma Virus (HPV)
Varicella
Herpes Zoster
Others
Global Pediatric Vaccine Market: By Technology
Recombinant Vaccines
Inactivated Vaccines
Conjugate Vaccines
Toxoid Vaccines
Live Attenuated Vaccines
Global Pediatric Vaccine Market: By Administration Method
Oral
Intramuscular
Subcutaneous
Global Pediatric Vaccine Market: By End-User
Hospitals
Healthcare Providers
Others
Global Pediatric Vaccine Market: By Region
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa